0001157523-18-002016.txt : 20181004 0001157523-18-002016.hdr.sgml : 20181004 20181004172007 ACCESSION NUMBER: 0001157523-18-002016 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20181003 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20181004 DATE AS OF CHANGE: 20181004 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CROSS COUNTRY HEALTHCARE INC CENTRAL INDEX KEY: 0001141103 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HELP SUPPLY SERVICES [7363] IRS NUMBER: 134066229 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-33169 FILM NUMBER: 181108522 BUSINESS ADDRESS: STREET 1: 5201 CONGRESS AVENUE STREET 2: SUITE 100B CITY: BOCA RATON STATE: FL ZIP: 33487 BUSINESS PHONE: 8003472264 MAIL ADDRESS: STREET 1: 5201 CONGRESS AVENUE STREET 2: SUITE 100B CITY: BOCA RATON STATE: FL ZIP: 33487 FORMER COMPANY: FORMER CONFORMED NAME: CROSS COUNTRY INC DATE OF NAME CHANGE: 20010521 8-K 1 a51877548.htm CROSS COUNTRY HEALTHCARE, INC. 8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 Date of Report (Date of earliest event reported) October 3, 2018

GRAPHIC


Cross Country Healthcare, Inc.
 (Exact name of registrant as specified in its charter)


Delaware

  0-33169   13-4066229

(State or Other Jurisdiction
of Incorporation)

(Commission
File Number)

(I.R.S. Employer
Identification No.)

5201 Congress Avenue, Suite 100B, Boca Raton, FL 33487
(Address of Principal Executive Office) (Zip Code)

(561) 998-2232
 (Registrant’s telephone number, including area code)

Not Applicable
 (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



ITEM 8.01

Other Events.

Incorporated by reference is a press release issued by the Company on October 3, 2018 and attached hereto as Exhibit 99.1.  This information is being furnished under Item 8.01 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of such section.

Item 9.01

Financial Statements and Exhibits

(d) Exhibits


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.


CROSS COUNTRY HEALTHCARE, INC.
 
 
 

Dated:

Dated: October 4, 2018

By:

/s/ Christopher R. Pizzi

Name:  Christopher R. Pizzi

 

 

Title: SVP, Chief Financial Officer

EX-99.1 2 a51877548ex99_1.htm EXHIBIT 99.1

Exhibit 99.1

Cross Country Healthcare Announces Third Quarter 2018 Earnings Release Date and Conference Call Information

BOCA RATON, Fla.--(BUSINESS WIRE)--October 3, 2018--Cross Country Healthcare, Inc. (Nasdaq:CCRN) will hold its quarterly conference call to discuss its third quarter 2018 financial results on Wednesday, October 31, 2018 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the “Company”) intends to distribute its earnings press release after market close on Wednesday, October 31, 2018.

This call will be webcast live and can be accessed at the Company’s website at www.crosscountryhealthcare.com or by dialing 800-857-6331 from anywhere in the U.S. or by dialing 517-623-4781 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from October 31st through November 14th at the Company’s website and a replay of the conference call will be available by telephone by calling 800-944-9725 from anywhere in the U.S. or 402-220-3524 from non-U.S. locations – Passcode: 2018.

About Cross Country Healthcare

Cross Country Healthcare is a national leader in providing innovative healthcare workforce solutions and staffing services. Our solutions leverage our nearly 40 years of expertise and insight to assist clients in solving complex labor-related challenges while maintaining high quality outcomes. We are dedicated to recruiting and placing highly qualified healthcare professionals in virtually every specialty and area of expertise. Our diverse client base includes both clinical and nonclinical settings, servicing acute care hospitals, physician practice groups, outpatient and ambulatory-care centers, nursing facilities, both public schools and charter schools, rehabilitation and sports medicine clinics, government facilities, and homecare. Through our national staffing teams and network of 72 office locations, we are able to place clinicians on travel and per diem assignments, local short-term contracts and permanent positions. We are a market leader in providing flexible workforce management solutions, which include managed services programs (MSP), internal resource pool consulting and development, electronic medical record (EMR) transition staffing, recruitment process outsourcing, predictive modeling and other outsourcing and consultative services. In addition, we provide both retained and contingent placement services for healthcare executives, physicians, and other healthcare professionals.

Copies of this and other news releases as well as additional information about Cross Country Healthcare can be obtained online at www.crosscountryhealthcare.com. Shareholders and prospective investors can also register to automatically receive the Company's press releases, SEC filings and other notices by e-mail.

CONTACT:
Cross Country Healthcare, Inc.
William J. Grubbs, 561-237-6202
President and Chief Executive Officer
wgrubbs@crosscountry.com

GRAPHIC 3 logo.jpg LOGO begin 644 logo.jpg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end